Skip to content

Observation of the effect of different doses sulfentanil plus ropivacaine for Branchial Plexus Block anesthesia

Observation of the effect of different doses sulfentanil plus ropivacaine for Branchial Plexus Block anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019025
Enrollment
Unknown
Registered
2018-10-21
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulnar radius fracture

Interventions

Case series:Axillary brachial plexus block was performed only with 4% ropivacaine in group C. In S l-3 groups,axillary brachial plexus block was performed with the mixture of 4% ropivacaine and sufent

Sponsors

Department of Anesthesiology, Chifeng Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I or II, aged 18 to 50 years old, 45 ~ 75 kg weight; 2. All of them were anesthetized under the direction of ultrasound-guided transaxillary brachial plexus nerve block; 3. In this study, the axillary brachial plexus block was prepared by specialized physicians; 4. All puncture operations were performed by the same anesthesiologist; 5. The operation and postoperative follow-up doctors did not understand the grouping.

Exclusion criteria

Exclusion criteria: Abnormal peripheral cardiac function; Abnormal liver and kidney function; Inoculation site infection; , mental illness and drug allergy history; A history of cerebrovascular accidents; Upper limb sensory motor dysfunction; Chronic coagulation system disease; Today local anesthetics allergies; Non - conscious non - compliance.

Design outcomes

Primary

MeasureTime frame
The sensory and motor block onset times and the movement and sensory block maintenance time;

Countries

China

Contacts

Public ContactXizhe Zhang

Department of Anesthesiology, Chifeng Municipal Hospital

zhangxizhe1965@sina.com+86 13500660020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026